These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8621805

  • 21. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB.
    Blood; 1997 Jan 01; 89(1):155-65. PubMed ID: 8978288
    [Abstract] [Full Text] [Related]

  • 22. Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia.
    Patchen ML, Fischer R, Schmauder-Chock EA, Williams DE.
    Exp Hematol; 1994 Jan 01; 22(1):31-9. PubMed ID: 7506673
    [Abstract] [Full Text] [Related]

  • 23. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
    MacVittie TJ, Farese AM, Smith WG, Baum CM, Burton E, McKearn JP.
    Blood; 2000 Feb 01; 95(3):837-45. PubMed ID: 10648394
    [Abstract] [Full Text] [Related]

  • 24. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG, Briddell RA, Hill R, Gough M, McNiece IK.
    Stem Cells; 1999 Feb 01; 17(4):210-8. PubMed ID: 10437984
    [Abstract] [Full Text] [Related]

  • 25. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N, Chertkov J, Samoilina N, Zander A.
    Exp Hematol; 1996 Jun 01; 24(7):816-22. PubMed ID: 8647232
    [Abstract] [Full Text] [Related]

  • 26. Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation.
    Bolwell B, Vredenburgh J, Overmoyer B, Gilbert C, Chap L, Menchaca DM, Cruickshank S, Glaspy J.
    Bone Marrow Transplant; 2000 Jul 01; 26(2):141-5. PubMed ID: 10918423
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 01; 28(3):339-44. PubMed ID: 16900629
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates.
    Stahl CP, Winton EF, Monroe MC, Holman RC, Zelasky M, Liehl E, Myers LA, McClure H, Anderson D, Evatt BL.
    Exp Hematol; 1991 Sep 01; 19(8):810-6. PubMed ID: 1868895
    [Abstract] [Full Text] [Related]

  • 30. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 01; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
    Inoue H, Koezuka Y, Nishi N, Osawa M, Motoki K, Kobayashi E, Kabaya K, Obuchi M, Fukushima H, Mori KJ.
    Exp Hematol; 1997 Aug 01; 25(9):935-44. PubMed ID: 9257806
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].
    Ma YC, Li M, Xing S, Xiong GL, Shen X, Chen Q, Cong YW, Wang JX, Zhu NK, Yu ZY, Zhang XG.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr 01; 24(2):573-9. PubMed ID: 27151032
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study.
    Geissler K, Yin JA, Ganser A, Sanz MA, Szer J, Raghavachar A, Hoelzer D, Martinez C, Taylor K, Kanz L, To LB, Archimbaud E.
    Ann Hematol; 2003 Nov 01; 82(11):677-83. PubMed ID: 14530872
    [Abstract] [Full Text] [Related]

  • 40. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S, Media JE, Nakeff A.
    Stem Cells; 1998 Nov 01; 16(2):144-51. PubMed ID: 9554039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.